Global Wearable Injectors

Wearable Injectors Comprehensive Study by Type (Body-worn patch injectors, Off-body worn injectors), End-user (Hospital, Ambulatory Surgical Center, Homecare Setting) Players and Region - Global Market Outlook to 2026

Wearable Injectors Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Wearable Injectors Market Scope
Wearable injectors abbreviated as WIs, are the drug or vaccine delivery systems operates through adhering the body for monitoring the larger volumes (more than 2 mL) of drug subcutaneously over a longer time period. The WIs releases the huge volume of the viscous medication with the offering patients the freedom. These single-use systems can be worn on the body while maintaining the comfort of the user and promote the patient compliance thereby reducing the overall burden on healthcare services. The wearable injectors acts as excellent alternative for delivering the drugs, when oral route is not advised, shifting preference to intravenous (IV), intramuscular (IM), and/or subcutaneous (SC) injection. These delivery system has gained huge attention in the healthcare sector, as anew class of drug delivery platform. Disadvantage associated with the traditional drug delivery, with ground breaking advances in pharmaceutical sector has created inclination of the major pharmaceutical and medical delivery system manufacturer to develop a portable and wearable delivery device.

The Wearable Injectors market study is segmented by Type (Body-worn patch injectors and Off-body worn injectors) and major geographies with country level break-up.

The market is highly competitive due to pre-market approval required to market the product. However, ongoing development in the drug delivery system attracts new players. Research Analyst at AMA estimates that Players concentration is mainly in United States Players will contribute to the maximum growth of Global Wearable Injectors market throughout the predicted period.

BD (United States), Subcuject Aps (Denmark), Ypsomed AG (Switzerland), Insulet Corporation (United States), Amgen Inc. (United States), Tandem Diabetes Care, Inc. (United States), West Pharmaceutical Services (United States), CeQur SA (Switzerland), Eitan Medical (Israel), Sensile Medical AG (Switzerland), INQUEST SCIENCE (United States), Unilife Corporation (United States) and Phillips-Medisize - a Molex Company (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Bühler Motor GmbH (Germany) and Steadymed Therapeutics (Israel).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AMA Research has segmented the market of Global Wearable Injectors market by Type, Application and Region.

On the basis of geography, the market of Wearable Injectors has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

In February 2021, the Phillips-Medisize, a Molex company, a manufacturer of drug delivery, diagnostic products signed an agreement with the Subcuject, a Danish proprietary device platforms provider for wearable bolus injector. With this agreement, the On-Body Delivery System technology, is available for the next stage of drug-specific wearable injector solution development after the Subcuject's intellectual property filing. and In January 2021, Eitan Medical, advanced infusion therapy provider and drug delivery solutions unveiled upgrade of the Sapphire infusion pump system software Rev15. The Sapphire is the US Food and Drug Administration (FDA) 510(k) approved infusion pump system inclusive of infusion pump, administration sets and accessories. The Sapphire infusion system is used across the U.S. within alternate sites, homecare markets, emergency medical services (EMS) and hospitals.
In November 2020, Tandem Diabetes Care, US based company received approval from the Health Canada for the t:slim X2 insulin pump with Control-IQ technology. The product was previously launched in the United States.

Market Trend
  • Ongoing demand for home healthcare solution

Market Drivers
  • Growing demand for portable and self-injection device
  • Rise in prevalence of chronic medical condition
  • Growing Prevalence of Targeted Therapies

Opportunities
  • Ongoing research and development activities and clinical trials for wearable injector
  • Strong Product Pipeline


Challenges
  • Higher penetration of traditional fluid injection
  • Lack of trained patients for appropriate use of wearable injectors


Key Target Audience
Manufacturers of wearable injectors

Report Objectives / Segmentation Covered

By Type
  • Body-worn patch injectors
  • Off-body worn injectors
By End-user
  • Hospital
  • Ambulatory Surgical Center
  • Homecare Setting

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing demand for portable and self-injection device
      • 3.2.2. Rise in prevalence of chronic medical condition
      • 3.2.3. Growing Prevalence of Targeted Therapies
    • 3.3. Market Challenges
      • 3.3.1. Higher penetration of traditional fluid injection
      • 3.3.2. Lack of trained patients for appropriate use of wearable injectors
    • 3.4. Market Trends
      • 3.4.1. Ongoing demand for home healthcare solution
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Wearable Injectors, by Type, End-user and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Wearable Injectors (Value)
      • 5.2.1. Global Wearable Injectors by: Type (Value)
        • 5.2.1.1. Body-worn patch injectors
        • 5.2.1.2. Off-body worn injectors
      • 5.2.2. Global Wearable Injectors by: End-user (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Ambulatory Surgical Center
        • 5.2.2.3. Homecare Setting
      • 5.2.3. Global Wearable Injectors Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Wearable Injectors (Volume)
      • 5.3.1. Global Wearable Injectors by: Type (Volume)
        • 5.3.1.1. Body-worn patch injectors
        • 5.3.1.2. Off-body worn injectors
      • 5.3.2. Global Wearable Injectors by: End-user (Volume)
        • 5.3.2.1. Hospital
        • 5.3.2.2. Ambulatory Surgical Center
        • 5.3.2.3. Homecare Setting
      • 5.3.3. Global Wearable Injectors Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Wearable Injectors (Price)
      • 5.4.1. Global Wearable Injectors by: Type (Price)
  • 6. Wearable Injectors: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. BD (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Subcuject Aps (Denmark)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Ypsomed AG (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Insulet Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Amgen Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Tandem Diabetes Care, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. West Pharmaceutical Services (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. CeQur SA (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Eitan Medical (Israel)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Sensile Medical AG (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. INQUEST SCIENCE (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Unilife Corporation (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Phillips-Medisize - a Molex Company (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Wearable Injectors Sale, by Type, End-user and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Wearable Injectors (Value)
      • 7.2.1. Global Wearable Injectors by: Type (Value)
        • 7.2.1.1. Body-worn patch injectors
        • 7.2.1.2. Off-body worn injectors
      • 7.2.2. Global Wearable Injectors by: End-user (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Ambulatory Surgical Center
        • 7.2.2.3. Homecare Setting
      • 7.2.3. Global Wearable Injectors Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Wearable Injectors (Volume)
      • 7.3.1. Global Wearable Injectors by: Type (Volume)
        • 7.3.1.1. Body-worn patch injectors
        • 7.3.1.2. Off-body worn injectors
      • 7.3.2. Global Wearable Injectors by: End-user (Volume)
        • 7.3.2.1. Hospital
        • 7.3.2.2. Ambulatory Surgical Center
        • 7.3.2.3. Homecare Setting
      • 7.3.3. Global Wearable Injectors Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Wearable Injectors (Price)
      • 7.4.1. Global Wearable Injectors by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Wearable Injectors: by Type(USD Million)
  • Table 2. Wearable Injectors Body-worn patch injectors , by Region USD Million (2015-2020)
  • Table 3. Wearable Injectors Off-body worn injectors , by Region USD Million (2015-2020)
  • Table 4. Wearable Injectors: by End-user(USD Million)
  • Table 5. Wearable Injectors Hospital , by Region USD Million (2015-2020)
  • Table 6. Wearable Injectors Ambulatory Surgical Center , by Region USD Million (2015-2020)
  • Table 7. Wearable Injectors Homecare Setting , by Region USD Million (2015-2020)
  • Table 8. South America Wearable Injectors, by Country USD Million (2015-2020)
  • Table 9. South America Wearable Injectors, by Type USD Million (2015-2020)
  • Table 10. South America Wearable Injectors, by End-user USD Million (2015-2020)
  • Table 11. Brazil Wearable Injectors, by Type USD Million (2015-2020)
  • Table 12. Brazil Wearable Injectors, by End-user USD Million (2015-2020)
  • Table 13. Argentina Wearable Injectors, by Type USD Million (2015-2020)
  • Table 14. Argentina Wearable Injectors, by End-user USD Million (2015-2020)
  • Table 15. Rest of South America Wearable Injectors, by Type USD Million (2015-2020)
  • Table 16. Rest of South America Wearable Injectors, by End-user USD Million (2015-2020)
  • Table 17. Asia Pacific Wearable Injectors, by Country USD Million (2015-2020)
  • Table 18. Asia Pacific Wearable Injectors, by Type USD Million (2015-2020)
  • Table 19. Asia Pacific Wearable Injectors, by End-user USD Million (2015-2020)
  • Table 20. China Wearable Injectors, by Type USD Million (2015-2020)
  • Table 21. China Wearable Injectors, by End-user USD Million (2015-2020)
  • Table 22. Japan Wearable Injectors, by Type USD Million (2015-2020)
  • Table 23. Japan Wearable Injectors, by End-user USD Million (2015-2020)
  • Table 24. India Wearable Injectors, by Type USD Million (2015-2020)
  • Table 25. India Wearable Injectors, by End-user USD Million (2015-2020)
  • Table 26. South Korea Wearable Injectors, by Type USD Million (2015-2020)
  • Table 27. South Korea Wearable Injectors, by End-user USD Million (2015-2020)
  • Table 28. Taiwan Wearable Injectors, by Type USD Million (2015-2020)
  • Table 29. Taiwan Wearable Injectors, by End-user USD Million (2015-2020)
  • Table 30. Australia Wearable Injectors, by Type USD Million (2015-2020)
  • Table 31. Australia Wearable Injectors, by End-user USD Million (2015-2020)
  • Table 32. Rest of Asia-Pacific Wearable Injectors, by Type USD Million (2015-2020)
  • Table 33. Rest of Asia-Pacific Wearable Injectors, by End-user USD Million (2015-2020)
  • Table 34. Europe Wearable Injectors, by Country USD Million (2015-2020)
  • Table 35. Europe Wearable Injectors, by Type USD Million (2015-2020)
  • Table 36. Europe Wearable Injectors, by End-user USD Million (2015-2020)
  • Table 37. Germany Wearable Injectors, by Type USD Million (2015-2020)
  • Table 38. Germany Wearable Injectors, by End-user USD Million (2015-2020)
  • Table 39. France Wearable Injectors, by Type USD Million (2015-2020)
  • Table 40. France Wearable Injectors, by End-user USD Million (2015-2020)
  • Table 41. Italy Wearable Injectors, by Type USD Million (2015-2020)
  • Table 42. Italy Wearable Injectors, by End-user USD Million (2015-2020)
  • Table 43. United Kingdom Wearable Injectors, by Type USD Million (2015-2020)
  • Table 44. United Kingdom Wearable Injectors, by End-user USD Million (2015-2020)
  • Table 45. Netherlands Wearable Injectors, by Type USD Million (2015-2020)
  • Table 46. Netherlands Wearable Injectors, by End-user USD Million (2015-2020)
  • Table 47. Rest of Europe Wearable Injectors, by Type USD Million (2015-2020)
  • Table 48. Rest of Europe Wearable Injectors, by End-user USD Million (2015-2020)
  • Table 49. MEA Wearable Injectors, by Country USD Million (2015-2020)
  • Table 50. MEA Wearable Injectors, by Type USD Million (2015-2020)
  • Table 51. MEA Wearable Injectors, by End-user USD Million (2015-2020)
  • Table 52. Middle East Wearable Injectors, by Type USD Million (2015-2020)
  • Table 53. Middle East Wearable Injectors, by End-user USD Million (2015-2020)
  • Table 54. Africa Wearable Injectors, by Type USD Million (2015-2020)
  • Table 55. Africa Wearable Injectors, by End-user USD Million (2015-2020)
  • Table 56. North America Wearable Injectors, by Country USD Million (2015-2020)
  • Table 57. North America Wearable Injectors, by Type USD Million (2015-2020)
  • Table 58. North America Wearable Injectors, by End-user USD Million (2015-2020)
  • Table 59. United States Wearable Injectors, by Type USD Million (2015-2020)
  • Table 60. United States Wearable Injectors, by End-user USD Million (2015-2020)
  • Table 61. Canada Wearable Injectors, by Type USD Million (2015-2020)
  • Table 62. Canada Wearable Injectors, by End-user USD Million (2015-2020)
  • Table 63. Mexico Wearable Injectors, by Type USD Million (2015-2020)
  • Table 64. Mexico Wearable Injectors, by End-user USD Million (2015-2020)
  • Table 65. Wearable Injectors Sales: by Type(K Units)
  • Table 66. Wearable Injectors Sales Body-worn patch injectors , by Region K Units (2015-2020)
  • Table 67. Wearable Injectors Sales Off-body worn injectors , by Region K Units (2015-2020)
  • Table 68. Wearable Injectors Sales: by End-user(K Units)
  • Table 69. Wearable Injectors Sales Hospital , by Region K Units (2015-2020)
  • Table 70. Wearable Injectors Sales Ambulatory Surgical Center , by Region K Units (2015-2020)
  • Table 71. Wearable Injectors Sales Homecare Setting , by Region K Units (2015-2020)
  • Table 72. South America Wearable Injectors Sales, by Country K Units (2015-2020)
  • Table 73. South America Wearable Injectors Sales, by Type K Units (2015-2020)
  • Table 74. South America Wearable Injectors Sales, by End-user K Units (2015-2020)
  • Table 75. Brazil Wearable Injectors Sales, by Type K Units (2015-2020)
  • Table 76. Brazil Wearable Injectors Sales, by End-user K Units (2015-2020)
  • Table 77. Argentina Wearable Injectors Sales, by Type K Units (2015-2020)
  • Table 78. Argentina Wearable Injectors Sales, by End-user K Units (2015-2020)
  • Table 79. Rest of South America Wearable Injectors Sales, by Type K Units (2015-2020)
  • Table 80. Rest of South America Wearable Injectors Sales, by End-user K Units (2015-2020)
  • Table 81. Asia Pacific Wearable Injectors Sales, by Country K Units (2015-2020)
  • Table 82. Asia Pacific Wearable Injectors Sales, by Type K Units (2015-2020)
  • Table 83. Asia Pacific Wearable Injectors Sales, by End-user K Units (2015-2020)
  • Table 84. China Wearable Injectors Sales, by Type K Units (2015-2020)
  • Table 85. China Wearable Injectors Sales, by End-user K Units (2015-2020)
  • Table 86. Japan Wearable Injectors Sales, by Type K Units (2015-2020)
  • Table 87. Japan Wearable Injectors Sales, by End-user K Units (2015-2020)
  • Table 88. India Wearable Injectors Sales, by Type K Units (2015-2020)
  • Table 89. India Wearable Injectors Sales, by End-user K Units (2015-2020)
  • Table 90. South Korea Wearable Injectors Sales, by Type K Units (2015-2020)
  • Table 91. South Korea Wearable Injectors Sales, by End-user K Units (2015-2020)
  • Table 92. Taiwan Wearable Injectors Sales, by Type K Units (2015-2020)
  • Table 93. Taiwan Wearable Injectors Sales, by End-user K Units (2015-2020)
  • Table 94. Australia Wearable Injectors Sales, by Type K Units (2015-2020)
  • Table 95. Australia Wearable Injectors Sales, by End-user K Units (2015-2020)
  • Table 96. Rest of Asia-Pacific Wearable Injectors Sales, by Type K Units (2015-2020)
  • Table 97. Rest of Asia-Pacific Wearable Injectors Sales, by End-user K Units (2015-2020)
  • Table 98. Europe Wearable Injectors Sales, by Country K Units (2015-2020)
  • Table 99. Europe Wearable Injectors Sales, by Type K Units (2015-2020)
  • Table 100. Europe Wearable Injectors Sales, by End-user K Units (2015-2020)
  • Table 101. Germany Wearable Injectors Sales, by Type K Units (2015-2020)
  • Table 102. Germany Wearable Injectors Sales, by End-user K Units (2015-2020)
  • Table 103. France Wearable Injectors Sales, by Type K Units (2015-2020)
  • Table 104. France Wearable Injectors Sales, by End-user K Units (2015-2020)
  • Table 105. Italy Wearable Injectors Sales, by Type K Units (2015-2020)
  • Table 106. Italy Wearable Injectors Sales, by End-user K Units (2015-2020)
  • Table 107. United Kingdom Wearable Injectors Sales, by Type K Units (2015-2020)
  • Table 108. United Kingdom Wearable Injectors Sales, by End-user K Units (2015-2020)
  • Table 109. Netherlands Wearable Injectors Sales, by Type K Units (2015-2020)
  • Table 110. Netherlands Wearable Injectors Sales, by End-user K Units (2015-2020)
  • Table 111. Rest of Europe Wearable Injectors Sales, by Type K Units (2015-2020)
  • Table 112. Rest of Europe Wearable Injectors Sales, by End-user K Units (2015-2020)
  • Table 113. MEA Wearable Injectors Sales, by Country K Units (2015-2020)
  • Table 114. MEA Wearable Injectors Sales, by Type K Units (2015-2020)
  • Table 115. MEA Wearable Injectors Sales, by End-user K Units (2015-2020)
  • Table 116. Middle East Wearable Injectors Sales, by Type K Units (2015-2020)
  • Table 117. Middle East Wearable Injectors Sales, by End-user K Units (2015-2020)
  • Table 118. Africa Wearable Injectors Sales, by Type K Units (2015-2020)
  • Table 119. Africa Wearable Injectors Sales, by End-user K Units (2015-2020)
  • Table 120. North America Wearable Injectors Sales, by Country K Units (2015-2020)
  • Table 121. North America Wearable Injectors Sales, by Type K Units (2015-2020)
  • Table 122. North America Wearable Injectors Sales, by End-user K Units (2015-2020)
  • Table 123. United States Wearable Injectors Sales, by Type K Units (2015-2020)
  • Table 124. United States Wearable Injectors Sales, by End-user K Units (2015-2020)
  • Table 125. Canada Wearable Injectors Sales, by Type K Units (2015-2020)
  • Table 126. Canada Wearable Injectors Sales, by End-user K Units (2015-2020)
  • Table 127. Mexico Wearable Injectors Sales, by Type K Units (2015-2020)
  • Table 128. Mexico Wearable Injectors Sales, by End-user K Units (2015-2020)
  • Table 129. Wearable Injectors: by Type(USD/Units)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Wearable Injectors: by Type(USD Million)
  • Table 144. Wearable Injectors Body-worn patch injectors , by Region USD Million (2021-2026)
  • Table 145. Wearable Injectors Off-body worn injectors , by Region USD Million (2021-2026)
  • Table 146. Wearable Injectors: by End-user(USD Million)
  • Table 147. Wearable Injectors Hospital , by Region USD Million (2021-2026)
  • Table 148. Wearable Injectors Ambulatory Surgical Center , by Region USD Million (2021-2026)
  • Table 149. Wearable Injectors Homecare Setting , by Region USD Million (2021-2026)
  • Table 150. South America Wearable Injectors, by Country USD Million (2021-2026)
  • Table 151. South America Wearable Injectors, by Type USD Million (2021-2026)
  • Table 152. South America Wearable Injectors, by End-user USD Million (2021-2026)
  • Table 153. Brazil Wearable Injectors, by Type USD Million (2021-2026)
  • Table 154. Brazil Wearable Injectors, by End-user USD Million (2021-2026)
  • Table 155. Argentina Wearable Injectors, by Type USD Million (2021-2026)
  • Table 156. Argentina Wearable Injectors, by End-user USD Million (2021-2026)
  • Table 157. Rest of South America Wearable Injectors, by Type USD Million (2021-2026)
  • Table 158. Rest of South America Wearable Injectors, by End-user USD Million (2021-2026)
  • Table 159. Asia Pacific Wearable Injectors, by Country USD Million (2021-2026)
  • Table 160. Asia Pacific Wearable Injectors, by Type USD Million (2021-2026)
  • Table 161. Asia Pacific Wearable Injectors, by End-user USD Million (2021-2026)
  • Table 162. China Wearable Injectors, by Type USD Million (2021-2026)
  • Table 163. China Wearable Injectors, by End-user USD Million (2021-2026)
  • Table 164. Japan Wearable Injectors, by Type USD Million (2021-2026)
  • Table 165. Japan Wearable Injectors, by End-user USD Million (2021-2026)
  • Table 166. India Wearable Injectors, by Type USD Million (2021-2026)
  • Table 167. India Wearable Injectors, by End-user USD Million (2021-2026)
  • Table 168. South Korea Wearable Injectors, by Type USD Million (2021-2026)
  • Table 169. South Korea Wearable Injectors, by End-user USD Million (2021-2026)
  • Table 170. Taiwan Wearable Injectors, by Type USD Million (2021-2026)
  • Table 171. Taiwan Wearable Injectors, by End-user USD Million (2021-2026)
  • Table 172. Australia Wearable Injectors, by Type USD Million (2021-2026)
  • Table 173. Australia Wearable Injectors, by End-user USD Million (2021-2026)
  • Table 174. Rest of Asia-Pacific Wearable Injectors, by Type USD Million (2021-2026)
  • Table 175. Rest of Asia-Pacific Wearable Injectors, by End-user USD Million (2021-2026)
  • Table 176. Europe Wearable Injectors, by Country USD Million (2021-2026)
  • Table 177. Europe Wearable Injectors, by Type USD Million (2021-2026)
  • Table 178. Europe Wearable Injectors, by End-user USD Million (2021-2026)
  • Table 179. Germany Wearable Injectors, by Type USD Million (2021-2026)
  • Table 180. Germany Wearable Injectors, by End-user USD Million (2021-2026)
  • Table 181. France Wearable Injectors, by Type USD Million (2021-2026)
  • Table 182. France Wearable Injectors, by End-user USD Million (2021-2026)
  • Table 183. Italy Wearable Injectors, by Type USD Million (2021-2026)
  • Table 184. Italy Wearable Injectors, by End-user USD Million (2021-2026)
  • Table 185. United Kingdom Wearable Injectors, by Type USD Million (2021-2026)
  • Table 186. United Kingdom Wearable Injectors, by End-user USD Million (2021-2026)
  • Table 187. Netherlands Wearable Injectors, by Type USD Million (2021-2026)
  • Table 188. Netherlands Wearable Injectors, by End-user USD Million (2021-2026)
  • Table 189. Rest of Europe Wearable Injectors, by Type USD Million (2021-2026)
  • Table 190. Rest of Europe Wearable Injectors, by End-user USD Million (2021-2026)
  • Table 191. MEA Wearable Injectors, by Country USD Million (2021-2026)
  • Table 192. MEA Wearable Injectors, by Type USD Million (2021-2026)
  • Table 193. MEA Wearable Injectors, by End-user USD Million (2021-2026)
  • Table 194. Middle East Wearable Injectors, by Type USD Million (2021-2026)
  • Table 195. Middle East Wearable Injectors, by End-user USD Million (2021-2026)
  • Table 196. Africa Wearable Injectors, by Type USD Million (2021-2026)
  • Table 197. Africa Wearable Injectors, by End-user USD Million (2021-2026)
  • Table 198. North America Wearable Injectors, by Country USD Million (2021-2026)
  • Table 199. North America Wearable Injectors, by Type USD Million (2021-2026)
  • Table 200. North America Wearable Injectors, by End-user USD Million (2021-2026)
  • Table 201. United States Wearable Injectors, by Type USD Million (2021-2026)
  • Table 202. United States Wearable Injectors, by End-user USD Million (2021-2026)
  • Table 203. Canada Wearable Injectors, by Type USD Million (2021-2026)
  • Table 204. Canada Wearable Injectors, by End-user USD Million (2021-2026)
  • Table 205. Mexico Wearable Injectors, by Type USD Million (2021-2026)
  • Table 206. Mexico Wearable Injectors, by End-user USD Million (2021-2026)
  • Table 207. Wearable Injectors Sales: by Type(K Units)
  • Table 208. Wearable Injectors Sales Body-worn patch injectors , by Region K Units (2021-2026)
  • Table 209. Wearable Injectors Sales Off-body worn injectors , by Region K Units (2021-2026)
  • Table 210. Wearable Injectors Sales: by End-user(K Units)
  • Table 211. Wearable Injectors Sales Hospital , by Region K Units (2021-2026)
  • Table 212. Wearable Injectors Sales Ambulatory Surgical Center , by Region K Units (2021-2026)
  • Table 213. Wearable Injectors Sales Homecare Setting , by Region K Units (2021-2026)
  • Table 214. South America Wearable Injectors Sales, by Country K Units (2021-2026)
  • Table 215. South America Wearable Injectors Sales, by Type K Units (2021-2026)
  • Table 216. South America Wearable Injectors Sales, by End-user K Units (2021-2026)
  • Table 217. Brazil Wearable Injectors Sales, by Type K Units (2021-2026)
  • Table 218. Brazil Wearable Injectors Sales, by End-user K Units (2021-2026)
  • Table 219. Argentina Wearable Injectors Sales, by Type K Units (2021-2026)
  • Table 220. Argentina Wearable Injectors Sales, by End-user K Units (2021-2026)
  • Table 221. Rest of South America Wearable Injectors Sales, by Type K Units (2021-2026)
  • Table 222. Rest of South America Wearable Injectors Sales, by End-user K Units (2021-2026)
  • Table 223. Asia Pacific Wearable Injectors Sales, by Country K Units (2021-2026)
  • Table 224. Asia Pacific Wearable Injectors Sales, by Type K Units (2021-2026)
  • Table 225. Asia Pacific Wearable Injectors Sales, by End-user K Units (2021-2026)
  • Table 226. China Wearable Injectors Sales, by Type K Units (2021-2026)
  • Table 227. China Wearable Injectors Sales, by End-user K Units (2021-2026)
  • Table 228. Japan Wearable Injectors Sales, by Type K Units (2021-2026)
  • Table 229. Japan Wearable Injectors Sales, by End-user K Units (2021-2026)
  • Table 230. India Wearable Injectors Sales, by Type K Units (2021-2026)
  • Table 231. India Wearable Injectors Sales, by End-user K Units (2021-2026)
  • Table 232. South Korea Wearable Injectors Sales, by Type K Units (2021-2026)
  • Table 233. South Korea Wearable Injectors Sales, by End-user K Units (2021-2026)
  • Table 234. Taiwan Wearable Injectors Sales, by Type K Units (2021-2026)
  • Table 235. Taiwan Wearable Injectors Sales, by End-user K Units (2021-2026)
  • Table 236. Australia Wearable Injectors Sales, by Type K Units (2021-2026)
  • Table 237. Australia Wearable Injectors Sales, by End-user K Units (2021-2026)
  • Table 238. Rest of Asia-Pacific Wearable Injectors Sales, by Type K Units (2021-2026)
  • Table 239. Rest of Asia-Pacific Wearable Injectors Sales, by End-user K Units (2021-2026)
  • Table 240. Europe Wearable Injectors Sales, by Country K Units (2021-2026)
  • Table 241. Europe Wearable Injectors Sales, by Type K Units (2021-2026)
  • Table 242. Europe Wearable Injectors Sales, by End-user K Units (2021-2026)
  • Table 243. Germany Wearable Injectors Sales, by Type K Units (2021-2026)
  • Table 244. Germany Wearable Injectors Sales, by End-user K Units (2021-2026)
  • Table 245. France Wearable Injectors Sales, by Type K Units (2021-2026)
  • Table 246. France Wearable Injectors Sales, by End-user K Units (2021-2026)
  • Table 247. Italy Wearable Injectors Sales, by Type K Units (2021-2026)
  • Table 248. Italy Wearable Injectors Sales, by End-user K Units (2021-2026)
  • Table 249. United Kingdom Wearable Injectors Sales, by Type K Units (2021-2026)
  • Table 250. United Kingdom Wearable Injectors Sales, by End-user K Units (2021-2026)
  • Table 251. Netherlands Wearable Injectors Sales, by Type K Units (2021-2026)
  • Table 252. Netherlands Wearable Injectors Sales, by End-user K Units (2021-2026)
  • Table 253. Rest of Europe Wearable Injectors Sales, by Type K Units (2021-2026)
  • Table 254. Rest of Europe Wearable Injectors Sales, by End-user K Units (2021-2026)
  • Table 255. MEA Wearable Injectors Sales, by Country K Units (2021-2026)
  • Table 256. MEA Wearable Injectors Sales, by Type K Units (2021-2026)
  • Table 257. MEA Wearable Injectors Sales, by End-user K Units (2021-2026)
  • Table 258. Middle East Wearable Injectors Sales, by Type K Units (2021-2026)
  • Table 259. Middle East Wearable Injectors Sales, by End-user K Units (2021-2026)
  • Table 260. Africa Wearable Injectors Sales, by Type K Units (2021-2026)
  • Table 261. Africa Wearable Injectors Sales, by End-user K Units (2021-2026)
  • Table 262. North America Wearable Injectors Sales, by Country K Units (2021-2026)
  • Table 263. North America Wearable Injectors Sales, by Type K Units (2021-2026)
  • Table 264. North America Wearable Injectors Sales, by End-user K Units (2021-2026)
  • Table 265. United States Wearable Injectors Sales, by Type K Units (2021-2026)
  • Table 266. United States Wearable Injectors Sales, by End-user K Units (2021-2026)
  • Table 267. Canada Wearable Injectors Sales, by Type K Units (2021-2026)
  • Table 268. Canada Wearable Injectors Sales, by End-user K Units (2021-2026)
  • Table 269. Mexico Wearable Injectors Sales, by Type K Units (2021-2026)
  • Table 270. Mexico Wearable Injectors Sales, by End-user K Units (2021-2026)
  • Table 271. Wearable Injectors: by Type(USD/Units)
  • Table 272. Research Programs/Design for This Report
  • Table 273. Key Data Information from Secondary Sources
  • Table 274. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Wearable Injectors: by Type USD Million (2015-2020)
  • Figure 5. Global Wearable Injectors: by End-user USD Million (2015-2020)
  • Figure 6. South America Wearable Injectors Share (%), by Country
  • Figure 7. Asia Pacific Wearable Injectors Share (%), by Country
  • Figure 8. Europe Wearable Injectors Share (%), by Country
  • Figure 9. MEA Wearable Injectors Share (%), by Country
  • Figure 10. North America Wearable Injectors Share (%), by Country
  • Figure 11. Global Wearable Injectors: by Type K Units (2015-2020)
  • Figure 12. Global Wearable Injectors: by End-user K Units (2015-2020)
  • Figure 13. South America Wearable Injectors Share (%), by Country
  • Figure 14. Asia Pacific Wearable Injectors Share (%), by Country
  • Figure 15. Europe Wearable Injectors Share (%), by Country
  • Figure 16. MEA Wearable Injectors Share (%), by Country
  • Figure 17. North America Wearable Injectors Share (%), by Country
  • Figure 18. Global Wearable Injectors: by Type USD/Units (2015-2020)
  • Figure 19. Global Wearable Injectors share by Players 2020 (%)
  • Figure 20. Global Wearable Injectors share by Players (Top 3) 2020(%)
  • Figure 21. Global Wearable Injectors share by Players (Top 5) 2020(%)
  • Figure 22. BCG Matrix for key Companies
  • Figure 23. BD (United States) Revenue, Net Income and Gross profit
  • Figure 24. BD (United States) Revenue: by Geography 2020
  • Figure 25. Subcuject Aps (Denmark) Revenue, Net Income and Gross profit
  • Figure 26. Subcuject Aps (Denmark) Revenue: by Geography 2020
  • Figure 27. Ypsomed AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 28. Ypsomed AG (Switzerland) Revenue: by Geography 2020
  • Figure 29. Insulet Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 30. Insulet Corporation (United States) Revenue: by Geography 2020
  • Figure 31. Amgen Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Amgen Inc. (United States) Revenue: by Geography 2020
  • Figure 33. Tandem Diabetes Care, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Tandem Diabetes Care, Inc. (United States) Revenue: by Geography 2020
  • Figure 35. West Pharmaceutical Services (United States) Revenue, Net Income and Gross profit
  • Figure 36. West Pharmaceutical Services (United States) Revenue: by Geography 2020
  • Figure 37. CeQur SA (Switzerland) Revenue, Net Income and Gross profit
  • Figure 38. CeQur SA (Switzerland) Revenue: by Geography 2020
  • Figure 39. Eitan Medical (Israel) Revenue, Net Income and Gross profit
  • Figure 40. Eitan Medical (Israel) Revenue: by Geography 2020
  • Figure 41. Sensile Medical AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 42. Sensile Medical AG (Switzerland) Revenue: by Geography 2020
  • Figure 43. INQUEST SCIENCE (United States) Revenue, Net Income and Gross profit
  • Figure 44. INQUEST SCIENCE (United States) Revenue: by Geography 2020
  • Figure 45. Unilife Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 46. Unilife Corporation (United States) Revenue: by Geography 2020
  • Figure 47. Phillips-Medisize - a Molex Company (United States) Revenue, Net Income and Gross profit
  • Figure 48. Phillips-Medisize - a Molex Company (United States) Revenue: by Geography 2020
  • Figure 49. Global Wearable Injectors: by Type USD Million (2021-2026)
  • Figure 50. Global Wearable Injectors: by End-user USD Million (2021-2026)
  • Figure 51. South America Wearable Injectors Share (%), by Country
  • Figure 52. Asia Pacific Wearable Injectors Share (%), by Country
  • Figure 53. Europe Wearable Injectors Share (%), by Country
  • Figure 54. MEA Wearable Injectors Share (%), by Country
  • Figure 55. North America Wearable Injectors Share (%), by Country
  • Figure 56. Global Wearable Injectors: by Type K Units (2021-2026)
  • Figure 57. Global Wearable Injectors: by End-user K Units (2021-2026)
  • Figure 58. South America Wearable Injectors Share (%), by Country
  • Figure 59. Asia Pacific Wearable Injectors Share (%), by Country
  • Figure 60. Europe Wearable Injectors Share (%), by Country
  • Figure 61. MEA Wearable Injectors Share (%), by Country
  • Figure 62. North America Wearable Injectors Share (%), by Country
  • Figure 63. Global Wearable Injectors: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • BD (United States)
  • Subcuject Aps (Denmark)
  • Ypsomed AG (Switzerland)
  • Insulet Corporation (United States)
  • Amgen Inc. (United States)
  • Tandem Diabetes Care, Inc. (United States)
  • West Pharmaceutical Services (United States)
  • CeQur SA (Switzerland)
  • Eitan Medical (Israel)
  • Sensile Medical AG (Switzerland)
  • INQUEST SCIENCE (United States)
  • Unilife Corporation (United States)
  • Phillips-Medisize - a Molex Company (United States)
Additional players considered in the study are as follows:
Bühler Motor GmbH (Germany) , Steadymed Therapeutics (Israel)
Select User Access Type

Key Highlights of Report


Dec 2021 204 Pages 61 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Wearable Injectors Quantitative research analysis
Global Wearable Injectors Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2026.

Know More About Global Wearable Injectors Report?

Have a Query? Click Here

Other Related Reports

Radio Tower Comprehensive Study by Type (Angle Steel Tower, Steel Tube Power, Single-Pipe Tower, Radio Masts), Application (Communication, Broadcast, Television, Radar, Navigation), Deployment (Self-...
$ 3450
2G and 3G Switch Off Comprehensive Study by Type (Natural Shutdown, - Mix Of Customer Less Than 2%, Constrained Shutdown, - Government/Regulator Action, - Negative Competitive Positioning, Anticipate...
$ 3650
Telecom Enterprise Services Comprehensive Study by Type (Personal service, Enterprise service), Application (Web service, Communication services), Revenue Stream (Master Agent, Carriers, Others), End...
$ 3650
Vanilla Comprehensive Study by Application (Bakery, Cookies, Cakes & Pastries, Truffles & Muffins, Filling, - Custard, - Ganache, - Frosting, - Whipped Cream, - Others, Others, Confectionery, Hard Ca...
$ 3800
SIM Cards Comprehensive Study by Type (Full-size (85.6mm × 53.98mm × 0.76 mm), Mini-SIM (25mm x 15mm x 0.76mm), Micro-SIM (15mm x 12mm x 0.76mm), Nano-SIM (12.3mm × 8.8mm × 0.67mm)), Application (Mob...
$ 3450
System on Module Comprehensive Study by Type (ARM Architecture, X86 Architecture, Power Architecture, Other Architecture), Application (Industrial Automation, Medical, Entertainment, Transportation, ...
$ 3650